International professional education covering cannabinoid science, clinical practice, evidence, and regulatory frameworks — for healthcare professionals, researchers and policy leaders worldwide.
The Institute for Cannabinoid Therapy is an independent international educational organisation bringing together clinicians, scientists and regulatory experts from multiple jurisdictions. Together, they build a rigorous, evidence-based curriculum that advances the safe and responsible practice of cannabinoid therapeutics.
The evidence base for cannabinoid therapeutics is expanding at unprecedented pace.
Patients and colleagues are asking informed questions in every specialty.
Regulatory landscapes are shifting across most major jurisdictions.
Rigorous appraisal is essential to separate signal from noise.
Understanding benefits, limitations, contraindications and interactions.
A structured introduction to cannabinoid science, pharmacology, and clinical fundamentals for healthcare practitioners.
Focused, self-paced modules across pharmacology, cannabinoids and clinical indications.
Premium live teaching on pain, complex cases, emerging research, expert panels, regulation and clinical pearls.
On completing an Institute course, graduates are invited into an international alumni community of clinicians and researchers — with year-round continuing education, peer discussion and expert-led events that extend well beyond the classroom.
Membership is open to graduates of Institute courses.
Available to members, the library expands jurisdiction by jurisdiction — educational reviews comparing prescribing frameworks, product access, practitioner responsibilities and evolving evidence, updated as regulation changes.
Full reviews are held in the member library. Membership is granted to graduates of Institute courses.
These reviews are educational only and do not constitute legal advice. Regulations change frequently. Practitioners remain responsible for understanding and complying with local laws applicable to their jurisdiction and scope of practice.
The Institute is assembling clinicians, scientists, published authors and regulatory experts from across the continents. Faculty confirmations are being finalised and will be announced progressively as the inaugural program opens.
Each appointment is made with independence and educational integrity in mind — spanning ECS biology, clinical pharmacology, pain, mental health, women's health and regulatory science.
Learn moreEnrol in the Foundations Program or explore individual modules. Graduates are then invited into professional membership — continuing education, community and a growing library of regulatory landscape reviews.
